An industry survey conducted by KPMG and the Regulatory Affairs Professionals Society (RAPS) found little familiarity with the European Union’s new Medical Device Regulation and its requirements that take full effect in May 2020.
News & Trends
Procurar
Recentes
- HTA Regulation – Commission selects first medical devices for joint clinical assessment
- PHARMACOVIGILANCE UPDATE | FDA E2B(R3) IMPLEMENTATION GUIDE — OCTOBER 2026
- updated PIC/S PI 006-4 guideline RECOMMENDATIONS ON QUALIFICATION AND VALIDATION
- Annual report of the Pharmacovigilance Inspectors Working Group for 2025
- European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
- ACT EU workplan 2026 – 2027
- Advice on ‘end-of-year’ submission dates for type I variations in 2026
- EMA UPDATE : COMPLIANCE with EU GMP Annex 22 and Artificial Intelligence Standards